Long-term Reduction in Inhaled and Systemic Corticosteroid Exposure During Anti-interleukin 5 Therapy for Severe Asthma – A Nationwide Study from the Danish Severe Asthma Registry
Kåre Håkansson(Bispebjerg Hospital), Celeste Porsbjerg(Bispebjerg Hospital), Birgitte Bertelsen(Gentofte Hospital), Marianne Baastrup Soendergaard(Frederiksberg Hospital), Ole Hilberg(University of Southern Denmark), Radu Vijdea(Aalborg University Hospital), Susanne Hansen(University of Ioannina), Sofie Lock Johansson(Odense University Hospital), Charlotte Suppli Ulrik(University of Copenhagen), Anne Sofie Bjerrum(Aarhus University Hospital), Johannes Martin Schmid(Aarhus University Hospital), Claus Rikard Johnsen(Gentofte Hospital), Linda Makowska Rasmussen(Gentofte Hospital), Anna von Bülow(Frederiksberg Hospital)
American Journal of Respiratory and Critical Care Medicine
May 1, 2025
Cited by 0
Related Papers
Eosinophilic and Noneosinophilic Asthma
|CHEST Journal|2021|262
Clinical Response and Remission in Patients With Severe Asthma Treated With Biologic Therapies
|CHEST Journal|2023|139
Importance of genetic factors in the etiology of atopic dermatitis: A twin study
|Allergy and Asthma Proceedings|2007|131